BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Onconova Presents Data on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2017 Meeting

  The company’s lead compound, is being evaluated in Phase 3 and Phase 2 clinical trials in both intravenous and oral forms, respectively.

  December 12, 2017

   · 

  10 min read
• Business

  Sienna Biopharmaceuticals Establishes Corporate Advisory Board

  The Corporate Advisory Board comprises accomplished and highly regarded medical opinion leaders within dermatology and aesthetics.

  December 12, 2017

   · 

  5 min read
• Business

  CMC Biologics Announces Development and Manufacturing Agreement With Harpoon Therapeutics

  CMC Biologics and Harpoon Therapeutics announced today they have entered into an agreement for the development and manufacturing of HPN424, HPN536, and HPN217, representing three TriTAC molecules for the treatment of various human cancers.

  December 12, 2017

   · 

  3 min read
• Biotech Bay

  OmniTier’s Breakthrough CompStor Genome Assembly Software Stack Available Now

  OmniTier announces the availability of its flagship scientific computing product, CompStorTM Assembly, for de novo DNA assembly and reference alignment.

  December 12, 2017

   · 

  4 min read
• Genetown

  Acer Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock

  The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Acer, are expected to be approximately $11.0 million

  December 12, 2017

   · 

  4 min read
• Business

  Eyevensys Appoints Dr. Patricia Zilliox as CEO

  Dr. Zilliox, who joined the Eyevensys board in May 2016, has more than 25 years of global clinical development expertise.

  December 12, 2017

   · 

  1 min read
• Business

  Rockwell Medical Signs Exclusive License Agreement With Quimica Europea to Commercialize Triferic in Peru

  Triferic is the only FDA approved therapy to replace iron and maintain hemoglobin in hemodialysis patients suffering from anemia.

  December 12, 2017

   · 

  6 min read
• Business

  Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15

  The company will also hold a live investor conference call and webcast at 8:30am Eastern Time.

  December 12, 2017

   · 

  1 min read
• Lone Star Bio

  CertaDose Wins Johnson & Johnson Innovation Award for Advancing Safety in Healthcare

  The honor was presented to CertaDose founder and Chief Medical Officer Dr. Caleb Hernandez on Tuesday, November 28 in New York.

  December 12, 2017

   · 

  2 min read
• Business

  Roy Davis Joins Liquid Biopsy Company Clinical Genomics Board of Directors

  Mr. Davis joins the organization with over 30 years of experience in leadership and business development, strategic planning and creating joint ventures across the US, Europe and Japan.

  December 12, 2017

   · 

  2 min read